Annual report [Section 13 and 15(d), not S-K Item 405]

Document and Entity Information

v3.26.1
Document and Entity Information - USD ($)
shares in Thousands, $ in Thousands
12 Months Ended
May 31, 2026
Jun. 30, 2026
Nov. 30, 2025
Cover [Abstract]      
Document Type 10-K    
Document Annual Report true    
Document Period End Date May 31, 2026    
Document Transition Report false    
Securities Act File Number 000-49908    
Entity Registrant Name CytoDyn Inc.    
Entity Incorporation, State or Country Code DE    
Entity Tax Identification Number 83-1887078    
Entity Address, Address Line One 1111 Main Street    
Entity Address, Address Line Two Suite 660    
Entity Address, City or Town Vancouver    
Entity Address, State or Province WA    
Entity Address, Postal Zip Code 98660    
City Area Code 360    
Local Phone Number 980‑8524    
No Trading Symbol Flag true    
Title of 12(g) Security Common Stock, par value $0.001 per share    
Entity Well-known Seasoned Issuer No    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Filer Category Non-accelerated Filer    
Entity Small Business true    
Entity Emerging Growth Company false    
ICFR Auditor Attestation Flag false    
Document Financial Statement Error Correction [Flag] false    
Entity Shell Company false    
Entity Public Float     $ 417,678
Entity Common Stock, Shares Outstanding   1,381,942  
Auditor Name CBIZ CPAs P.C.    
Auditor Firm ID 199    
Auditor Location Hartford, CT    
Central Index Key 0001175680    
Current Fiscal Year End Date --05-31    
Document Fiscal Year Focus 2026    
Document Fiscal Period Focus FY    
Amendment Flag false    
Documents Incorporated by Reference [Text Block]

 

 

 

Document

Parts Into Which Incorporated

Portions of the Proxy Statement for the 2026 Annual Meeting of Stockholders

 

Part III